HIGH
SPARQL Injection in VIVO Vitro v1.10.0 allows a remote attacker to execute arbitrary SPARQL via the uri parameter, leading to a regular expression denial of service (ReDoS), as demonstrated by crafted use of FILTER%20regex in a /individual?uri= request
Published Jan 28, 2019
7.5
HIGHCVSS 3.0
EPSS 3.02%
Description
SPARQL Injection in VIVO Vitro v1.10.0 allows a remote attacker to execute arbitrary SPARQL via the uri parameter, leading to a regular expression denial of service (ReDoS), as demonstrated by crafted use of FILTER%20regex in a /individual?uri= request.
Affected products
Remediation
No remediation recorded yet.
Metrics
No CVSS v4.0 score for this CVE.
No CVSS v3.1 score for this CVE.
7.5 HIGH NVD
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Attack Vector Network
Attack Complexity Low
Privileges Required None
User Interaction None
Scope Unchanged
Confidentiality Impact None
Integrity Impact None
Availability Impact High
5.0 MEDIUM NVD
AV:N/AC:L/Au:N/C:N/I:N/A:P
Access Vector Network
Access Complexity Low
Authentication None
Confidentiality Impact None
Integrity Impact None
Availability Impact Partial
This CVE is not in the KEV list.
No CISA SSVC assessment for this CVE yet.
3.02% 0.03016
Estimated probability of exploitation in the wild in the next 30 days (FIRST EPSS). As of Oct 1, 2026.
EPSS probability 0.03016
Score over time
2021–2026- EPSS v1
- EPSS v2
- EPSS v3
- EPSS v5
Percentile over time
- EPSS v1
- EPSS v2
- EPSS v3
- EPSS v5
Table of values (15 key points)
Flat stretches are collapsed; showing up to 120 newest points.
| Date | Score | Percentile | Model |
|---|---|---|---|
| Oct 1, 2026 | 3.02% (0.03016) | 86.96th | v5 (v2026.06.15) |
| Jun 15, 2026 | 3.02% (0.03016) | 85.65th | v5 (v2026.06.15) |
| Jul 20, 2024 | 0.92% (0.00919) | 83.08th | v3 (v2023.03.01) |
| Jun 20, 2024 | 0.92% (0.00919) | 82.98th | v3 (v2023.03.01) |
| Jan 22, 2024 | 0.90% (0.00902) | 80.96th | v3 (v2023.03.01) |
| Jun 12, 2023 | 0.66% (0.00661) | 76.72th | v3 (v2023.03.01) |
| Mar 7, 2023 | 0.18% (0.00185) | 53.98th | v3 (v2023.03.01) |
| Mar 6, 2023 | 1.05% (0.01055) | 52.13th | v2 (v2022.01.01) |
| Sep 17, 2022 | 1.05% (0.01055) | 50.47th | v2 (v2022.01.01) |
| Apr 1, 2022 | 1.05% (0.01055) | 48.43th | v2 (v2022.01.01) |
| Feb 4, 2022 | 4.50% (0.04499) | 74.08th | v2 (v2022.01.01) |
| Feb 3, 2022 | 4.24% (0.04237) | 74.61th | v1 |
| Jan 6, 2022 | 4.24% (0.04237) | 74.40th | v1 |
| Sep 1, 2021 | 0.98% (0.00976) | 61.78th | v1 |
| Apr 14, 2021 | 0.98% (0.00976) | 0.00th | v1 |
Weaknesses (2)
References (7)
- http://packetstormsecurity.com/files/172838/VIVO-SPARQL-Injection.html
- https://github.com/advisories/GHSA-hgq9-q8g2-3jmg Advisory
- https://github.com/kevinbackhouse/SecurityExploits/tree/0ec74459ac53685a7959ed58d580ef8abece3685/vivo-project ExploitThird Party Advisory
- https://github.com/vivo-project/Vitro/pull/111 PatchThird Party Advisory
- https://github.com/vivo-project/Vitro/pull/111/commits/248ef19107a5ac6f86304fd8f3bc75f3787f8d49
- https://jira.duraspace.org/browse/VIVO-1697
- https://nvd.nist.gov/vuln/detail/CVE-2019-6986
Change history (0)
No recorded changes yet.
Sources
CVE.org / MITRE
Status PUBLISHED
Assigner mitre
Published Jan 28, 2019
Updated Sep 16, 2024
Reserved Jan 28, 2019
Link CVE-2019-6986
CISA Vulnrichment
GHSA-HGQ9-Q8G2-3JMG Updated n/a